Thursday, February 16, 2012

US Patent 8114807 - Iron palladium nanoparticles

This patent from CEM Corporation involves a new type of nanoparticle catalyst for pharmaceutical synthesis which are reusable, active, can be readily synthesized, and are appropriate for scale-up. Claim 1 reads:

1. A composition comprising:

particles of an intermetallic magnetic compound of iron oxide and palladium having a nanometer particle size; and

wherein at least about 70% by weight of the palladium present in the particles is present on the surface of the nanometer size particles.